UC75: Opioid Risk Scoring Agent

The Problem

The opioid epidemic has driven federal and state mandates requiring prescriber and pharmacy oversight of opioid prescriptions. Prescribers must screen patients for opioid use disorder risk, check state Prescription Drug Monitoring Program (PDMP) data before prescribing, and avoid "red flags" (multiple prescribers, early refills, high doses). However, manual PDMP checks are time-consuming and inconsistent; many prescribers do not check PDMP before prescribing. Pharmacists catch high-risk prescriptions but lack systematic risk assessment; decisions are subjective. Without consistent risk identification, high-risk patients continue receiving opioids, feeding addiction and contributing to overdose deaths.

What the Agent Does

Opioid Risk Scoring: Calculates risk scores for every patient receiving opioid prescription using validated instruments (Opioid Risk Tool, SOAPP-R); considers patient age, medical history, substance use history, psychological factors.
PDMP Real-Time Monitoring: Queries state PDMP data in real-time when opioid prescription is submitted; identifies red flags: multiple concurrent prescribers (>2), short fills (early refills), concurrent benzodiazepine/alcohol use, high daily morphine equivalent doses (MME >50 to 90 mg).
Prescription Alert Generation: For high-risk prescriptions (risk score >high, PDMP red flags), generates alert for pharmacist; alert includes specific risks and recommended actions (e.g., "Patient has received opioid prescriptions from 3 prescribers in past 30 days,recommend patient confirmation before dispensing").
Prescriber Communication: For prescriptions from prescribers with historically high-risk prescribing patterns, alerts prescriber via EHR message with patient risk factors and PDMP findings; suggests dose reduction or alternative pain management.
Patient Education Trigger: For high-risk patients receiving opioids, triggers educational content about opioid risks, addiction warning signs, and alternatives (e.g., physical therapy, non-opioid analgesics).
Monitoring Recommendations: For high-risk patients on chronic opioids, recommends monitoring cadence (follow-up visits, urine drug screens, pain contracts); documents recommendations for continuity of care.

Data Requirements

Aspect	Details
Data Sources	Opioid prescription data (pharmacy system), patient demographics and history (EHR), state PDMP data (queries via PDMP gateway), opioid risk assessment scores (patient history), benzodiazepine and alcohol use data (EHR, PDMP), prescriber history (claims data).
Data Classification	PHI (medical history, PDMP data), DEA restricted data (opioid prescriptions, PDMP queries)
Data Quality Needs	High , PDMP data must be current (real-time queries); risk assessment criteria must reflect current clinical guidelines; prescriber data must be complete.
Complexity	Moderate-to-High , PDMP integration across states (variable APIs); risk scoring logic; alert generation.

Score Breakdown

Criterion	Weight	Score (1-5)	Weighted
Time Recaptured	15%	4	0.60
Error Reduction	10%	4	0.40
Cost Avoidance	10%	4	0.40
Strategic Leverage	5%	4	0.20
Data Availability	15%	4	0.60
Process Clarity	15%	4	0.60
Ease of Implementation	10%	4	0.40
Fallback Available	10%	4	0.40
Audience (Int/Ext)	10%	4	0.40
Composite	100%		3.85

Why It Scores Well

Public Health Crisis: Opioid epidemic is national emergency; prescriber/pharmacy vigilance is critical intervention.
Regulatory Mandate: Many states mandate PDMP checks; CMS/OIG focus on opioid stewardship; agent ensures compliance.
Clear Clinical Impact: Risk identification directly prevents high-risk opioid prescribing; overdose prevention documented in literature.
Measurable Compliance: PDMP check rate, alert generation rate, prescriber response rate all measurable.
Stakeholder Alignment: Prescribers want to avoid regulatory scrutiny; patients want safe pain management; pharmacies want to prevent liability. Agent aligns all incentives.

Regulatory Alignment

State PDMP Mandates: Agent integrates with state PDMP systems; ensures compliance with state-specific PDMP requirements.
CDC Opioid Prescribing Guidelines: Risk scoring and monitoring recommendations aligned with CDC guidelines.
DEA Regulations: Agent respects DEA controlled substance prescribing rules; prevents illegal opioid distribution.
CMS Oversight: CMS monitors opioid prescribing; agent supports institutional compliance.

Sprint Factory Fit

Moderate-High Fit. PDMP integration is complex (50 states, variable APIs, sometimes requiring custom gateways). Risk scoring logic is well-established (ORT, SOAPP-R are published tools). Initial build: 6 weeks for core risk scoring + initial PDMP integration (starting with 3 to 5 major states). Full PDMP coverage: 12+ weeks for all 50 states + territories. Deployment: Pharmacy dispensing system integration + prescriber EHR alerts. Ongoing: 2 weeks/sprint for new state integrations and guideline updates.

Comparable Implementations

Prescription Monitoring Program Interconnect (PMIX) , PDMP integration infrastructure.
PDMP Training & Compliance Resources , PDMP regulatory guidance.
Opioid Risk Assessment Tools (ORT, SOAPP-R) , Risk assessment baseline.

Deploy This Use Case with the Sprint Factory

From zero to a governed, production agent in 6 weeks.

Sprint Factory Schedule a Briefing

Related Use Cases

Workflow Pharmacy/Clinical

Pharmacy Prior Authorisation (Provider Side)

Score: 3.9/5.0

Batch Pharmacy/Clinical

Clinical Pharmacist Review (MTM)

Score: 3.65/5.0

On-Demand Pharmacy/Clinical

Pill Identification Agent

Score: 3.35/5.0